Skip to Content

Levemir Approval History

FDA Approved: Yes (First approved June 16, 2005)
Brand name: Levemir
Generic name: insulin detemir
Dosage form: Injection
Company: Novo Nordisk Inc.
Treatment for: Diabetes, Type 1, Diabetes, Type 2

Levemir (insulin detemir) is a novel, long- acting form of insulin that provides up to a 24-hour duration of action for the treatment of diabetes mellitus (type 1 and type 2).

Development History and FDA Approval Process for Levemir

DateArticle
May 22, 2012Approval FDA Approves Levemir for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes
Apr  2, 2012Approval FDA Approves Levemir Pregnancy Category Change for Women with Diabetes
Jun 16, 2005Approval Levemir Novo Nordisk Inc. - Treatment for Diabetes Mellitus (Type 1 and Type 2)

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide